Phase 1-2 Study of Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome (DRWMNTMS)

NCT02503865 Phase 1/Phase 2 COMPLETED Results posted

Metabolic syndrome: aetiology, pathogenesis, diagnosis, clinical management and prognosis

Details

Lead sponsor	Nazarbayev University
Phase	Phase 1/Phase 2
Status	COMPLETED
Enrolment	351
Start date	2003-01
Completion	2014-12

Conditions

• Metabolic Syndrome

Interventions

• Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin
• "Analimentary detoxication"

Primary outcomes

• Blood Glucose Level — up to 12 weeks
  Fasting blood glucose (FBG) (mmole/L) and Two-hour postprandial glucose (THPG) (mmole/L) were measured.
• Systolic/ Diastolic Blood Pressures (mm Hg) — up to 12 weeks
  Systolic and Diastolic Blood Pressures (mm Hg) was measured by manual/automatic tonometery

Countries

Kazakhstan